Analisis Jumlah Trombosit Pada Pasien Terinfeksi Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)
Abstract
Tujuan: Penelitian bertujuan untuk mengetahui jumlah trombosit pada pasien terinfeksi SARS-CoV-2. Metode: Penelitian deskriptif cross sectional terhadap 123 pasien terinfeksi SARS-CoV-2 yang memenuhi kriteria inklusi dan eksklusi. Penelitian dilakukan mulai bulan Juli-September 2020 di Laboratorium Sentral RSUP Dr M Djamil Padang. Pemeriksaan jumlah trombosit dilakukan dengan alat hematologi otomatis metode Hydrodynamic Focusing DC Detection. Pemeriksaan trombosit dilakukan saat awal rawatan. Data jumlah trombosit disajikan dalam bentuk tabel distribusi frekuensi. Hasil: Sampel penelitian perempuan (58,5%) lebih banyak daripada laki-laki (41,5%), rerata umur 47,8(15,6) tahun. Rentang umur pasien yaitu 21-82 tahun. Kelompok umur 30-39 dan 50-59 terbanyak yang terinfeksi SARS-CoV-2. Rerata jumlah trombosit 295.154(108.783) /mm3. Trombositopenia ditemukan pada 6 pasien (4,9%), trombositosis pada 17 pasien (13,8%) dan jumlah trombosit normal pada 100 pasien (81,3%). Jumlah kematian dengan trombositopenia sebanyak 1 pasien (16,7%). Jumlah kematian dengan trombosit normal sebanyak 13 pasien (13%). Jumlah kematian dengan trombositosis sebanyak 4 pasien (23,5%). Simpulan: Jumlah trombosit pasien terinfeksi SARS-CoV-2 memperlihatkan trombositopenia 4,9% dan trombositosis 13,8%.
Kata kunci: COVID-19 ; SARS-CoV-2 ; trombosit.
Full Text:
PDFReferences
Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J et al. Mechanisms Involved in the Development of Thrombocytopenia in Patients with COVID-19. Thrombosis Research 193 (2020) 110–115
WHO. Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. 2020. Tersedia dari www.who.int/emergencies/disease/novel-coronavirus-2019/situation-reports/
Provinsi Sumatera Barat, 2020. Daftar Corona Sumbar, diunduh dari corona.sumbarprov.go.id
Dinas Kesehatan Padang, 2020. Situasi Perkembangan COVID-19 di Kota Padang, diunduh dari dinkes.padang.go.id
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu G M et al. Coronavirus Disease 2019 (COVID-19)): A Perspective from China. Radiology. 2020
Joly BS, Siguret V, Veyradier A. Understanding Pathophysiology of Hemostasis Disorders in Critically ill Patients with COVID‑19. Intensive Care Med (2020) 46:1603–1606
Perhimpunan Dokter Paru Indonesia, 2020. Pneumonia COVID-19, Jakarta
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Critical Reviews in Clinical Laboratory Sciences 2020, Vol. 57, No. 6, 389–399
Xu P, Zhou Q, Xu J. Mechanism of Thrombocytopenia in COVID-19 Patients. Annals of Hematology (2020) 99: 1205-1208
Yang X, Yang Q, Wang Y, Wu Y, Xu J, Yu Y et al. Thrombocytopenia and Its Association with Mortality in Patients with COVID-19. J Thromb Haemost (2020)18:1469-1472
Maquet J, Lafaurie M, Somnet A, Moulis G. Thrombocytopenia in COVID-19. British Journal of Haematology (2020)190: 276-279
Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. AJR 2020; 215:338–343
Shang W, Dong J, Ren Y, Tian M, Li W, Hu J et al. The Value of Clinical Parameters in Predicting the Severity of COVID‐19. J Med Virol. 2020;92:2188–2192
Jin J, Bai P, He W, Wu F, Liu X, Han D et al. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality. Frontiers in Public Health. 2020;8
Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X et al. Demographic science aids in understanding the spread and fatality rates of COVID-19. PNAS. 2020;117: 9696-9698
Amgalan A, Othman M. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets, 2020; 31(6): 740–745
Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18:2103–2109
Qu R, Ling Y, Zhang Y, Wei L, Chen X, Li X et al. Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19. J Med Virol. 2020;92:1533–1541.
